학술논문
Lenvatinib ± Pembrolizumab Versus Chemotherapy for Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC) That Progressed after Platinum and Immunotherapy: The Phase 2 LEAP-009 Study
Document Type
Abstract
Author
Source
In International Journal of Radiation Oncology, Biology, Physics 1 April 2024 118(5):e42-e42
Subject
Language
ISSN
0360-3016